Minimally Invasive Bi-Atrial CryoMaze Operation for Atrial Fibrillation  by Rodriguez, Evelio et al.
M
C
E
W
T
t
d
g
t
o

o
r
s
a
t
q
b
t
m
b
w
m
s
c
f
n
t
f
f
v
f
*
†
‡
W
A
2inimally Invasive Bi-Atrial
ryoMaze Operation for Atrial Fibrillation
velio Rodriguez, MD,* Richard C. Cook, MD,† Michael W.A. Chu, MD,‡ and
. Randolph Chitwood, Jr, MD*m
a
t
a
p
t
t
t
p
t
i
t
(
s
a
g
h
a
s
i
a
c
C
w
t
P
c

a
s
c
(
C
p
R
r
F
i
dhe Cox maze III operation (CMIII) pioneered by Dr. Cox
remains the gold standard for treatment of atrial fibrilla-
ion (AF); however, it has yet to gain widespread application
ue to its perceived invasiveness and complexity. The “holy
rail” for AF therapy is a safe, minimally invasive procedure
hat can provide the same freedom from AF as the CMIII
peration, which has achieved 96% freedom from AF at
5 years mean follow-up.1
Patients prefer a sternotomy-sparing approach, which
ffers cosmetic advantages and may allow for earlier
ecovery of normal function. However, these objectives
hould not affect the primary objective of eliminating AF
nd minimizing the risk of late thromboembolism. With
he introduction of catheter-based unipolar radiofre-
uency ablation (RFA), interventional treatment of AF has
ecome increasingly popular.2 However, catheter-based
echniques are often laborious and time-consuming and
ost results have been disappointing. Unipolar RFA has
een found to be a potentially dangerous energy source
hether used percutaneously or surgically, with develop-
ent of fatal left atrial to esophageal fistulas in both in-
tances.3 In addition, catheter-based RFA cannot create a
omplete left atrial lesion set. To offer patients 90%
reedom from AF and cerebral thromboembolism, pulmo-
ary vein isolation alone is likely to be inadequate. Despite
he work of Haissaguerre and coworkers,4 the experience
rom the Cleveland Clinic has demonstrated that the lesion
rom the pulmonary veins to the mitral valve annulus is
ery important and reduced their rates of recurrent AF
rom 40% to 20% at 1 year.5 This may explain why
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doi:10.1053/j.optechstcvs.2009.06.009ost reports of long-term follow-up after percutaneous AF
blation show only 70% to 80% freedom from AF. In addi-
ion, and perhaps more importantly, the left atrial append-
ge (LAA) is left open when using a percutaneous ap-
roach, thereby leaving patients with the potential for
hromboembolism, as 90% of left atrial thrombus is felt
o originate from the LAA.6 At this moment, percutaneous
reatment of AF remains an imperfect means of managing
atients with AF.
With the introduction of multiple new energy sources in-
ended to simulate “cut and sew” lesions, there is renewed
nterest in surgical AF ablation. Apart from cryothermy, all of
he new energy sources currently in use for AF ablation
unipolar or bipolar RFA, microwave, high-frequency ultra-
ound, and laser) are limited by their potential to damage
djacent structures, such as the atrial endothelium, esopha-
us, coronary arteries, or valvular tissues. Cryothermy
as always been an important part of the CMIII operation7
nd is the only energy source currently available that can
afely re-create all of the lesions of the CMIII operation,
ncluding the lesions down to the mitral and tricuspid
nnuli.
Traditional cryothermy was delivered by a liquid nitrogen-
ooled probe (Frigitronics; CooperSurgical Inc, Trumbull,
T), which achieved temperatures of approximately60°C,
ith probes that were not very flexible. Current cryothermy
echnology uses argon gas as the refrigerant (CryoMaze
robe; ATS Medical, Plymouth, MN)8 and provides faster
ryothermy to the tissues, with temperatures as low as
160°C, delivered by a flexible, linear probe. Studies of
nimal tissues have demonstrated effective transmural le-
ion creation after application of the Cryocath probe to
ardiac tissues of up to 4 mm thickness for 60 seconds
Surgifrost Chronic Dosing Study, communication from
ryocath). In addition, cryothermy has an excellent safety
rofile, causing less endothelial damage than unipolar
FA (noted by an absence of char formation), with no
eports of esophageal injury or left atrial fistula formation.
inally, the CryoMaze probe is well suited to a minimally
nvasive or robotic approach because it is a flexible, linear
evice with a 4-mm diameter, available in lengths of 6 to
0 cm.
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Minimally invasive bi-atrial CryoMaze operation 209We believe that the other critical factor affecting long-term
reedom from AF after surgical ablation is the lesion set.
lthough there is a large interest in minimally invasive tech-
iques that apply energy epicardially, these approaches suf-
er from an inability to reliably create the lesion from the
ulmonary vein orifices to the mitral valve annulus—a lesion
hat is important for prevention of left atrial flutter and recur-
ent AF postoperatively, as noted by the Cleveland Clinic
xperience.5 This is the reason our technique involves cardio-Contraindications to a minimally invasive approach in-
lude previous right lung surgery or dense adhesions,
orced expiratory volume 1 L, or significant peripheral
ascular disease. If a patient requires concomitant coro-
ary artery bypass or aortic valve surgery, the CryoMaze
peration can still be performed through a sternotomy
ncision.
We present our technique of the minimally invasive
ryoMaze, along with early results in a small group of pa-ulmonary bypass, cardiac arrest, and endocardial lesions. tients with isolated AF.
210 E. Rodriguez et alOperative Technique
Figure 1 (A) The patient is positioned supine with a slight 30° left lateral decubitus position. The right arm is wrapped in a flexed
position, beside the patient, to expose as much of the axilla as possible. Double-lumen endotracheal intubation is employed and
transesophageal echocardiography (TEE) is used in each patient in addition to other standard monitoring devices. A 3- to 4-cm
minithoracotomyincision iscreated in theright inframammarycreaseandthepleural space isenteredthroughthe fourth intercostal
space (ICS). (B)Asoft-tissue retractor (Edwards, Irvine,CA) isplacedwithminimumribspreading toexpose themediastinum.The
pericardium is opened 3 cm anterior to the phrenic nerve and pericardial and diaphragmatic retention sutures, 2-0 Ticron (US
Surgical Corp, Norwalk, CT), are exteriorized as far posteriorly as possible to maximize intrathoracic working space. A 5-mm
videoscope (Storz, Tuttlingen, Germany) is placed directly through the chest incision or through a 5-mm stabwound posterior to
the incision in the fourth ICS to facilitate deep intracardiac visualization. PC peripheral cannulation; MTminithoracotomy.
Minimally invasive bi-atrial CryoMaze operation 211Figure 2 Peripheral cannulation is achieved by exposing the femoral vessels through a 2-cm horizontal groin incision.
Only the anterior surfaces of each vessel are exposed and 4-0 Prolene purse-string sutures (Johnson and JohnsonHealth
Care Systems, Piscataway, NJ) are placed for cannulation. The patient is systemically heparinized. Using a Seldinger
guide-wire technique with TEE guidance, we routinely perform right femoral arterial (17-19 Fr) and venous cannu-
lation (21 Fr) using Bio-Medicus thin-wall cannulas (Medtronic-BioMedicus, Eden Prairie, MN). The venous cannula
is guided to rest at the mid-right atrium level. In addition, a right internal jugular venous drainage line (15-17 Fr) is
placed by the anesthesiologist in the distal superior vena cava well above the superior cavoatrial junction, before central
line placement. Kinetic-assisted venous drainage is used in every case. Cardiopulmonary bypass (CPB) is initiated and
the patient is cooled to 28°C.Tapes are place around the superior and inferior vena cava in preparation for the right-sided lesions. a.  artery.
212 E. Rodriguez et alFigure 3 A long antegrade cardiople-
gia/aortic root vent needle (Med-
tronic) is placed in the ascending aorta.
(A) A small stab wound is made as far
superior and posterior as possible in the
axilla to allow the Chitwood transtho-
racic aortic cross-clamp (Scanlan Inter-
national, Minneapolis, MN) to be
passed through the second ICS. (B) It is
then applied through the transverse si-
nus with the concave aspect of the
blades (C) facing cranially. Great care is
taken to avoid injury to the pulmonary
artery, left atrial appendage, and left
main coronary artery. After the aorta
has been cross-clamped, cold, intermit-
tent, antegrade blood cardioplegia is
used formyocardial protection. a. ar-
tery; SVC superior vena cava.
Minimally invasive bi-atrial CryoMaze operation 213Figure 4 The surgical field is flooded with CO2 via a 14-Fr angiocatheter, introduced through the right chest wall. The
interatrial groove is developed with electrocautery and the left atrium is opened. The oblique sinus is developed with
sharp or blunt dissection, and the left atriotomy incision is extended caudad posterior to the inferior vena cava, and
anterior to the right inferior pulmonary vein. A weighted-tip DLP sump catheter (Medtronic) is placed via a separate
stab incision on the chest wall near the aortic cross-clamp, through the atriotomy to rest in the left superior pulmonary
vein. This allows the pulmonary vestibule to be free of pooled blood. Exposure of the left atrium can be facilitated with
a handheld basket-type retractor or with a fixed blade retractor system (Estech, Danville, CA). A 5-mm videoscope
(Storz) can be passed through the incision for assisted vision or through a separate port incision as shown in Figure 1A.
In general, this minimally invasive approach provides superior visualization of all deeper cardiac structures, with
minimal surgical exposure. SVC  superior vena cava.
214 E. Rodriguez et alFigure 5 All lesions are created by applying the CryoMaze Probe (ATS Medical) for 2 minutes directly to myocardial
tissue with temperatures reaching 140°C to 160°C. Following lesion creation, the probe is thawed from the
surrounding tissue by administering cold saline for the left-sided lesions and room temperature saline for the right-
sided lesions. The left-sided lesions are created under cardiac standstill and the right-sided lesions are created on the
beating heart, while rewarming.
The left-sided endocardial lesions are performed first. The pulmonary vestibule is isolated as a single island with a
wide box lesion around it. The first cryo-lesion is performed on the inferior aspect of the pulmonary vestibule along the
atrial ridge that separates the pulmonary vestibule from the mitral valve. PV  pulmonary vein.
Minimally invasive bi-atrial CryoMaze operation 215Figure 6 The next cryo-lesion extends around the lateral aspect of the left pulmonary veins, between the orifice of the
LAA and the left superior pulmonary vein. Great care is taken to avoid skip lesions by ensuring complete contact
between the probe and atrial tissue along the entire lesion and crossing well over the last lesion to form a connection.
PV  pulmonary vein.
216 E. Rodriguez et alFigure 7 The box lesion is completed by a cryo-lesion across the superior aspect of the pulmonary veins that connects
with the left atriotomy incision, which is the only non-cryo-lesion of the pulmonary vein isolation. In general, the box
lesion can be constructed with 2 or 3 cryo-lesions; however, if the left atrium is particularly large and redundant, more
lesions may be required.
We create an additional lesion from the pulmonary vein isolation box to the LAA if this area was not completely
ablated during the creation of the pulmonary vein isolation box. PV  pulmonary vein.
Minimally invasive bi-atrial CryoMaze operation 217Figure 8 An endocardial lesion is then created to join the box lesion around the pulmonary veins to the mitral valve
annulus at the level of P3. By extending this lesion medially toward P3, the lesion can be created while avoiding
circumflex coronary artery injury. Most of our recurrent AF after the CryoMaze operation, as identified in the electro-
physiology laboratory, has originated from this lesion line incompletely crossing the annulus. As a result, we routinely
place the Cryo probe across the entire mitral annulus on to the posterior leaflet. We have not experienced any injury to
the leaflet with appropriate thawing of the leaflet tissue. PV  pulmonary vein.
218 E. Rodriguez et alFigure 9 The final left atrial lesion is an epicardial lesion across the coronary sinus, via the oblique sinus. As demon-
strated in the drawing, this lesion ensures complete transmurality at the mitral valve annulus. The videoscope can be
helpful to allow accurate placement of the CryoMaze probe across the coronary sinus. We place a suction catheter
posterior and lateral to the CryoMaze probe to prevent the probe from freezing the oblique sinus closed, making it
difficult to extricate the probe, and to protect the left phrenic nerve, which may lie just adjacent to probe. It is crucial
that this lesion incorporates the coronary sinus and that it is parallel and right on top of the endocardial lesion toward
P3. Alternatively this lesion can be created first and a mark in the left atrial endocardium with methylene blue could be
made to delineate the location for the endocardial lesion extending toward P3 to have both lesions on top of each other.
Minimally invasive bi-atrial CryoMaze operation 219Figure 10 The LAA is routinely closed as part of the CryoMaze operation, unless there are significant pericardial
adhesions keeping the appendage patent, for example, during reoperative cardiac surgery. The LAA is closed in a
2-layer fashion using a 3-0 Gore-Tex (W.L. Gore & Associates, Flagstaff, AZ) suture. The suture bites should be within
the thicker tubular portion, away from the trabeculated portion, of the LAA to allow complete appendage obliteration
without tearing.
The left atrium is then de-aired and closed with a running 3-0 Prolene suture. The transthoracic aortic cross-clamp
can now be removed; rewarming can begin and the right-sided lesions can be performed with the heart beating.
220 E. Rodriguez et alFigure 11 The intercaval lesion is created between the superior vena cava and the inferior vena cava, avoiding both the
sinoatrial node as well as the left atriotomy incision. Alternatively, the intercaval lesion could be created at the
beginning of the procedure, before cardiac arrest and opening of the left atrium, and thus obviating the potential for
freezing over your left atriotomy suture line. This lesion can usually be created with 1 freeze but may require 2 freezes.
Care is taken at this point to avoid contact between the CryoMaze probe and the phrenic nerve. A small surgical sponge
could be placed at the peri-cardio-caval reflections to protect the phrenic nerve.
Minimally invasive bi-atrial CryoMaze operation 221Figure 12 We recommend performing a small vertical atriotomy as an inverted T connecting to the intercaval lesion after
securing the caval tapes. Two endocardial lesions are created, 1 toward the tricuspid annulus at the 2 o’clock position
and another between the right atrial appendage and the tricuspid annulus at the 10 o’clock position.
222 E. Rodriguez et alFigure 13 Alternatively, a puncture site is made in the midbody of the right atrium and an endocardial lesion is created
along the endocardial surface of the right atrium out to the tricuspid valve annulus anteriorly. This lesion is performed
on full cardiopulmonary bypass with the atrium emptied, ensuring contact between the endocardium and the
CryoMaze probe. The right atrium is then filled to thaw the probe and separate it from the tissue. Caval tapes are usually
not required.
The atriotomy incision shown in Figure 12 is replaced by an epicardial cryolesion, shown in Figure 13 as the second
lesion connecting between the tricuspid lesion and the intercaval lesion, with the tip of the catheter aiming toward the
oblique sinus. After completion of this lesion, a 4-0 Prolene purse-string is placed to close the small right atrial stab
wound.
Temporary ventricular and atrial pacing wires are placed, and then the patient is weaned from CPB. After
de-airing is confirmed by TEE, the vented cardioplegia cannula is removed and the purse-string is secured. Once
hemostasis of the suture lines has been achieved, the protamine is administered, and the femoral artery and vein
are decannulated.
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Minimally invasive bi-atrial CryoMaze operation 223ostoperative Management
atients are loaded with intravenous amiodarone over the
rst 24 postoperative hours (1 mg/min IV  6 hours, then
.5 mg/min IV 18 hours) and then switched to oral amio-
arone. Amiodarone is not administered, or is discontinued,
n patients with bradycardia (heart rate60), heart block, or
vidence of adverse reaction/toxicity. Electrical cardioversion
s attempted in the operating room if the patient is in AF after
iscontinuation of CPB, or if he/she is hemodynamically un-
table in the recovery period. All patients are also restarted on
arfarin therapy once the pacing wires and chest tubes have
een removed, to a target INR of 2 to 3.
Patients are routinely monitored with CardioNet monitor-
ng (CardioNet, Conshohocken, PA), a continuous loop re-
order, for 1 week at 3, 6, and 12 months following surgery.
e feel this is more accurate than electrocardiogram “spot”
hecks and is absolutely necessary to determine the long-
erm efficacy of any AF ablation procedure. If CardioNet
onitoring demonstrates sinus rhythm at 3 months, after
eing off amiodarone for 1 month, warfarin therapy is dis-
ontinued. Monitoring is then repeated at 6 months and 1
ear after the initial procedure as well as yearly thereafter or
n the event of symptom development.
onclusions
t the East Carolina Heart Institute, it was our goal to develop
n AF operation that offered a minimally invasive approach,
hile at the same time allowing for re-creation of the CMIII
esions, including closure of the LAA. Between September
003 and August 2008, we performed a total of 333
ryoMaze operations; 71 were performed for lone AF and
62 were performed as a concomitant procedure, most com-
only with mitral valve surgery. Every 1 of the stand-alonerocedures was performed using the minimally invasive
echniques described here without sternotomy conversions.
Our initial results in the stand-alone group demonstrated
estoration of sinus rhythm in approximately 88% (off anti-
rrhythmic medications and warfarin) with at least 6-month
ollow-up on every patient.
The CryoMaze probe system may combine greater safety
nd efficacy, along with the added advantage of easy appli-
ability via a small unilateral inframammary incision. Further
tudies of randomized patients are necessary to determine the
ptimal treatment of AF—a therapeutic option that will pro-
ide patients with a minimally invasive, yet safe and highly
ffective treatment of their illness.
eferences
. Prasad SM, Maniar HS, Camillo CJ, et al: The Cox maze III procedure for
atrial fibrillation: long-term efficacy in patients undergoing lone versus
concomitant procedures. J Thorac Cardiovasc Surg 126:1822-1828,
2003
. Morady F: Catheter ablation of supraventricular arrhythmias: state of the
art. PACE 27:125-142, 2004
. Doll N, Borger MA, Fabricius A, et al: Esophageal perforation during left
atrial radiofrequency ablation: is the risk too high? J Thorac Cardiovasc
Surg 125:836-842, 2003
. Haissaguerre M, Jais P, Shah DC, et al: Spontaneous initiation of atrial
fibrillation by ectopic beats originating in the pulmonary veins. N Engl
J Med 339:659-666, 1998
. Gillinov AM, Bhavani S, Blackstone EH, et al: Surgery for permanent
atrial fibrillation: impact of patient factors and lesion set. Ann Thorac
Surg 82:502-514, 2006
. Stollberger C, Finsterer J, Ernst G, et al: Is left atrial appendage occlusion
useful for prevention of stroke or embolism in atrial fibrillation? Z Kar-
diol 91:376-379, 2002
. Cox JL, Jaquiss RDB, Schuessler RB, et al: Modification of the maze
procedure for atrial flutter and atrial fibrillation II. Surgical techinique of
the maze III procedure. J Thorac Cardiovasc Surg 110:485-495, 1995
. Doll N, Meyer R, Walther R, et al: A new cryoprobe for intraoperative
ablation of atrial fibrillation. Ann Thorac Surg 77:1460-1462, 2004
